Protein kinase Cδ mediates retinoic acid and phorbol myristate acetate-induced phospholipid scramblase 1 gene expression: Its role in leukemic cell differentiation

Blood

Volumn 104, Issue 12, 2004, Pages 3731-3738

  Zhao, Ke Wen ^a   Li, Xi ^a   Zhao, Qian ^a   Huang, Ying ^a   Li, Dong ^a   Peng, Zhen Gang ^a   Shen, Wu Zhong ^a   Zhao, Ji ^a   Zhou, Quansheng ^a   Chen, Zhu ^a   Sims, Peter J ^a   Wiedmer, Therese ^a   Chen, Guo Qiang ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRIC ACID; DIMETHYL SULFOXIDE; MEMBRANE PHOSPHOLIPID; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C DELTA; RETINOIC ACID; SCRAMBLASE; MEMBRANE PROTEIN; PHOSPHOLIPID TRANSFER PROTEIN; PRKCD PROTEIN, HUMAN; PROTEIN KINASE C; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CELL STRAIN U937; CONTROLLED STUDY; ENZYME ACTIVATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; LEUKEMIA; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; DRUG EFFECT; GENETICS; METABOLISM; PATHOLOGY; PHOSPHORYLATION; TUMOR CELL LINE; UPREGULATION;

CELL DIFFERENTIATION; CELL LINE, TUMOR; HUMANS; LEUKEMIA; MEMBRANE PROTEINS; PHOSPHOLIPID TRANSFER PROTEINS; PHOSPHORYLATION; PROTEIN KINASE C; PROTEIN KINASE C-DELTA; RNA, SMALL INTERFERING; TETRADECANOYLPHORBOL ACETATE; TRETINOIN; UP-REGULATION;

EID: 9444260940     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2004-04-1630     Document Type: Article

References (41)

1. Basse F, Stout JG, Sims PJ, Wiedmer T. Isolation of an erythrocyte membrane protein that mediates Ca2+-dependent transbilayer movement of phospholipid. J Biol Chem. 1996;271:17205-17210.
2. Zhou Q, Zhao J, Stout JG, Luhm RA, Wiedmer T, Sims PJ. Molecular cloning of human plasma membrane phospholipid scramblase: a protein mediating transbilayer movement of plasma membrane phospholipids. J Biol Chem. 1997;272:18240-18244.
3. Kasukabe T, Kobayashi H, Kaneko Y, Okabe-Kado J, Honma Y. Identity of human normal counterpart (MmTRA1b) of mouse leukemogenesis-associated gene (MmTRA1a) product as plasma membrane phospholipid scramblase and chromosome mapping of the human MmTRA1b/phospholipid scramblase gene. Biochem Biophys Res Commun. 1998;249:449-455.
4. Sims PJ, Wiedmer T. Unraveling the mysteries of phospholipid scrambling. Thromb Haemost. 2001;86:266-275.
5. Yu A, McMaster CR, Byers DM, Ridgway ND, Cook HW. Stimulation of phosphatidylserine biosynthesis and facilitation of UV-induced apoptosis in Chinese hamster ovary cells overexpressing phospholipid scramblase 1. J Biol Chem. 2003;278:9706-9714.
6. Kato N, Nakanishi M, Hirashima N. Transbilayer asymmetry of phospholipids in the plasma membrane regulates exocytotic release in mast cells. Biochemistry. 2002;41:8068-8074.
7. Zhao J, Zhou Q, Wiedmer T, Sims PJ. Level of expression of phospholipid scramblase regulates induced movement of phosphatidylserine to the cell surface. J Biol Chem. 1998;273:6603-6606.
8. Fadeel B, Gleiss B, Hogstrand K, et al. Phosphatidylserine exposure during apoptosis is a cell-type-specific event and does not correlate with plasma membrane phospholipid scramblase expression. Biochem Biophys Res Commun. 1999;266:504-511.
9. Zhou Q, Zhao J, Al-Zoghaibi F, Zhou A, Wiedmer T, Silverman RH, Sims PJ. Transcriptional control of the human plasma membrane phospholipid scramblase 1 gene is mediated by interferon-alpha. Blood. 2000;95:2593-2599.
10. Zhou Q, Zhao J, Wiedmer T, Sims PJ. Normal hemostasis but defective hematopoietic response to growth factors in mice deficient in phospholipid scramblase 1. Blood. 2002;99:4030-4038.
11. Sun J, Zhao J, Schwartz MA, Wang JY, Wiedmer T, Sims PJ. c-Abl tyrosine kinase binds and phosphorylates phospholipid soramblase 1. J Biol Chem. 2001;276:28984-28990.
12. Sun J, Nanjundan M, Pike LJ, Wiedmer T, Sims PJ. Plasma membrane phospholipid scramblase 1 is enriched in lipid rafts and interacts with the epidermal growth factor receptor. Biochemistry. 2002;41:6338-6345.
13. Nanjundan M, Sun J, Zhao J, Zhou Q, Sims PJ, Wiedmer T. Plasma membrane phospholipid scramblase 1 promotes EGF-dependent activation of c-Src through the epidermal growth factor receptor. J Biol Chem. 2003;278:37413-37418.
14. Frasch SC, Henson PM, Kailey JM, et al. Regulation of phospholipid scramblase activity during apoptosis and cell activation by protein kinase Cdelta. J Biol Chem. 2000;275:23065-23073.
15. Der SD, Zhou A, Williams BR, Silverman RH. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc Natl Acad Sci USA. 1998;95:15623-15628.
16. Wiedmer T, Zhao J, Nanjundan M, Sims PJ. Palmitoylation of phospholipid scramblase 1 controls its distribution between nucleus and plasma membrane. Biochemistry. 2003;42:1227-1233.
17. Ben-Efraim I, Zhou Q, Wiedmer T, Gerace L, Sims PJ. Phospholipid scramblase 1 is imported into the nucleus by a receptor-mediated pathway and interacts with DNA. Biochemistry. 2004;43:3518-3526.
18. Nakamaki T, Okabe-Kado J, Yamamoto-Yamaguchi Y, et al. Role of MmTRA1b/phospholipid scramblasel gene expression in the induction of differentiation of human myeloid leukemia cells into granulocytes. Exp Hematol. 2002;30:421-429.
19. Freemantle SJ, Spinella MJ, Dmitrovsky E. Retinoids in cancer therapy and chemoprevention: promise meets resistance. Oncogene. 2003;22:7305-7315.
20. Yokoyama A, Yamashita T, Shiozawa E, et al. MmTRA1b/phospholipid scramblase 1 gene expression is a new prognostic factor for acute myelogenous leukemia. Leuk Res. 2004;28:149-157.
21. Lanotte M, Martin-Thouvenin V, Najman S, Balerini P, Valensi F, Berger R. NB4, a maturation inducible cell line with t(15:17) marker isolated from a human acute promyelocytic leukemia(M3). Blood. 1991;77:1081-1086.
22. Roussel MJ, Lanotte M. Maturation sensitive and resistant t(15,17) NB4 cell lines as tools for APL physiopathology: nomenclature of cells and repertory of their known genetic alterations and phenotypes. Oncogene. 2001;20:7287-7291.
23. DeVries TA, Neville MC, Reyland ME. Nuclear import of PKC is required for apoptosis: identification of a novel nuclear import sequence. EMBO J. 2002;21:6050-6060.
24. 3 exerts dose-dependent dual effects on APL cells. Blood. 1997;89:3345-3353.
25. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001;29:2002-2007.
26. Kielbassa K, Muller HJ, Meyer HE, Marks F, Gschwendt M. Protein kinase C delta-specific phosphorylation of the elongation factor eEF-alpha and an eEF-1 alpha peptide at threonine 431. J Biol Chem. 1995;270:6156-6162.
27. Zhu J, Shi XG, Chu HY, et al. Effect of retinoic acid isomers on proliferation, differentiation and PML relocalization in the APL cell line NB4. Leukemia. 1995;9:302-309.
28. Ruchaud S, Duprez E, Gendron MC, et al. Two distinctly regulated events, priming and triggering, during retinoid-induced maturation and resistance of NB4 promyelocytic leukemia cell line. Proc Natl Acad Sci U S A. 1994;91:8428-8432.
29. Atsumi Y, Dodd RC, Maddux FW, Citron SJ, Gray TK. Retinoids induce U937 cells to express macrophage phenotype. Am J Med Sci. 1986;292:152-156.
30. Marques-Silva VM, De Souza MH, Teixeira MC, Arcuri RA, Rumjanek VM. Myeloid leukemia differentiation by phorbol ester and retinoic acid: a practical approach. J Clin Lab Anal. 1990;4:342-349.
31. Kosugi H, Towatari M, Hatano S, et al. Histone deacetylase inhibitors are the potent inducer/enhancer of differentiation in acute myeloid leukemia: a new approach to anti-leukemia therapy. Leukemia. 1999;13:1316-1324.
32. Ahmed N, Williams JF, Weidemann MJ. The human promyelocytic HL60 cell line: a model of myeloid cell differentiation using dimethylsulphoxide, phorbol ester and butyrate. Biochem Int. 1991;23:591-602.
33. Ward JO, McConnell MJ, Carlile GW, Pandolfi PP, Licht JD, Freedman LP. The acute promyelocytic leukemia-associated protein, promyelocytic leukemia zinc finger, regulates 1,25-dihydroxyvitamin D3-induced monocytic differentiation of U937 cells through a physical interaction with vitamin D3 receptor. Blood. 2001;98;3290-3300.
34. Cartee L, Wang Z, Decker RH, et al. The cyclin-dependent kinase inhibitor (CDKI) flavopiridol disrupts phorbol 12-myristate 13-acetate-induced differentiation and CDKI expression while enhancing apoptosis in human myeloid leukemia cells. Cancer Res. 2001;61:2583-2591.
35. Susarla BT, Robinson MB. Rottlerin, an inhibitor of protein kinase Cdelta (PKCdelta), inhibits astrocytic glutamate transport activity and reduces GLAST immunoreactivity by a mechanism that appears to be PKCdelta-independent. J Neurochem. 2003;86:635-645.
36. Huang ME, Ye YC, Chen SR, et al. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood. 1988;72:567-572.
37. Leszczyniecka M, Roberts T, Dent P, Grant S, Fisher PB. Differentiation therapy of human cancer: basic science and clinical applications. Pharmacol Ther. 2001;90:105-156.
38. Mistry AR, Pedersen EW, Solomon E, Grimwade D. The molecular pathogenesis of acute promyelocytic leukaemia: implications for the clinical management of the disease. Blood Rev. 2003;17:71-97.
39. Castagna M, Takai Y, Kaibuchi K, Sano K, Kikkawa U, Nishizuka Y. Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters. J Biol Chem. 1982;257:7847-7851.
40. Radominska-Pandya A, Chen G, Czernik PJ, et al. Direct interaction of all-trans-retinoic acid with protein kinase C (PKC): implications for PKC signaling and cancer therapy. J Biol Chem. 2000;275:22324-22330.
41. Kambhampati S, Li Y, Verma A, et al. Activation of protein kinase C delta by all-trans-retinoic acid. J Biol Chem. 2003;278:32544-32551.